Patent assignee · US · COMPANY

Eureka Therapeutics, Inc.

🏢 View company profile →
49Patents
48Active
49Granted
51Portfolio score

Filing activity: Jul 21, 2009 → May 27, 2021 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9540448B2 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2 Chemistry; Metallurgy 27 Active
US9074000B2 T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2 Chemistry; Metallurgy 26 Active
US10464988B2 Antibody/T-cell receptor chimeric constructs and uses thereof Chemistry; Metallurgy 13 Active
US10098951B2 Antibody/T-cell receptor chimeric constructs and uses thereof Chemistry; Metallurgy 13 Active
US10011658B2 Constructs targeting AFP peptide/MHC complexes and uses thereof Chemistry; Metallurgy 8 Active
US11155615B2 Anti-ROR1 antibodies Physics 7 Active
US10822389B2 Antibody/T-cell receptor chimeric constructs and uses thereof Chemistry; Metallurgy 7 Active
US10562972B2 Antibodies targeting B-cell maturation antigen and methods of use Physics 7 Active
US10918665B2 Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof Chemistry; Metallurgy 6 Active
US10239952B2 Anti-WT1/HLA bi-specific antibody Chemistry; Metallurgy 6 Active
US10821135B2 Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereof Chemistry; Metallurgy 5 Active
US10947314B2 Antibodies targeting b-cell maturation antigen and methods of use Physics 4 Active
US11000549B2 Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof Chemistry; Metallurgy 4 Active
US11117964B2 Anti-KIR3DL1 antibodies Chemistry; Metallurgy 4 Active
US10822413B2 Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof Chemistry; Metallurgy 4 Active
US10913796B2 Antibodies targeting Fc receptor-like 5 and methods of use Chemistry; Metallurgy 3 Active
US11725059B2 Antibodies targeting B-cell maturation antigen and methods of use Physics 2 Active
US10040865B2 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2 Chemistry; Metallurgy 2 Active
US10590196B2 Antibodies targeting G-protein coupled receptor and methods of use Physics 2 Active
US11421013B2 Antibody/T-cell receptor chimeric constructs and uses thereof Chemistry; Metallurgy 2 Active
US10906956B2 Methods of treatments using chimeric antigen receptors targeting G-protein coupled receptor Chemistry; Metallurgy 2 Active
US10301388B2 Antibody agents specific for human CD19 and uses thereof Chemistry; Metallurgy 1 Active
US11613573B2 Chimeric antibody/T-cell receptor constructs and uses thereof Chemistry; Metallurgy 1 Active
US11059891B2 Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof Chemistry; Metallurgy 1 Active
US10633426B2 Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.